HomeNewsNeuroscienceEpilepsy

  • Xenon includes Phase 3 Ready molecule in pipeline for Epilepsy

    • September 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Marijuana-Based Epilepsy Drug, Epidiolex priced at $32,500 for a Year

    • August 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive Ph 3 results announced for Zogenix’s ZX008 in Epilepsy Trial

    • July 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Epidiolex approved by FDA for severe forms of epilepsy

    • June 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Series A Financing raised for Epilepsy Drug-Device Combination Therapy

    • June 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Anti Epileptic drug launched in the US market by Dr Reddy’s

    • June 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Court confirms validity of UCB’s Vimpat patent for Epilepsy

    • May 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Futureneuro & Greenlight Medicines partner to develop new Epilepsy treatments

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Lyrica® (Pregabalin) meets primary endpoint in Pediatric Epilepsy Ph 3 Trial

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Focal cortical dysplasia in Epilepsy associated with dysregulation of gene NEUROG2

    • May 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • 1
  • 2